{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001759",
      "entity_text" : "PTX",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10415",
      "entity_text" : "BCL-2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "However, blockade of BCL-2 activity using siBCL-2 decreased this overexpression and promoted the therapeutic effect of PTX.",
  "reading_complete" : "2020-08-02T14:55:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:54:42Z",
  "trigger" : "promoted",
  "evidence" : [ "BCL-2 activity using siBCL-2 decreased this overexpression and promoted the therapeutic effect of PTX" ],
  "pmc_id" : "6376180",
  "score" : 0
}